# Claritas Pharmaceuticals, Inc. (CLAZF)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/CLAZF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2021 | $ 0 | $ -4.83M | $ -557.5K | $ 548.0K | $ 3.28M |
| 2020 | $ 0 | $ 5.36M | $ -393.6K | $ 925.0K | $ 1.51M |
| 2019 | $ 0 | $ -27.38M | $ -8.37M | $ 736.0K | $ -3.44M |
| 2018 | $ 0 | $ 9.17M | $ -6.40M | $ 246.0K | $ 9.76M |
| 2017 | $ 0 | $ -42.92M | $ -7.49M | $ 2.87M | $ -11.63M |
| 2016 | $ 0 | $ -18.85M | $ -2.71M | $ 0 | $ 2.92M |
| 2015 | $ 0 | $ -138.2K | $ -22.4K | $ 0 | $ 441.0K |
| 2014 | $ 0 | $ -72.4K | $ -2.10M | $ 0 | $ -1.24M |
| 2013 | $ 701.8K | $ -28.46M | $ -20.71M | $ 0 | $ -1.22M |
| 2012 | $ 1.36M | $ -35.80M | $ -14.71M | $ 0 | $ 21.18M |
| 2011 | $ 2.54M | $ -32.46M | $ -33.44M | $ 0 | $ 45.34M |
| 2010 | $ -47.7K | $ -8.90M | $ -24.10M | $ 0 | $ 34.59M |
| 2009 | $ 57.2K | $ -5.71M | $ -8.20M | $ 0 | $ 24.61M |
| 2008 | $ 2.7K | $ -30.53M | $ -11.35M | $ 184.1K | $ 9.37M |
| 2007 | $ 0 | $ -1.44M | $ -9.76M | $ 0 | $ 29.15M |
| 2006 | $ 0 | $ -586.3K | $ -197.2K | $ 0 | $ 705.5K |
| 2005 | $ 0 | $ -218.5K | $ -284.1K | $ 0 | $ 989.8K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.17 |
| Liabilities / Eq | 2.36 |
| Current Ratio | 1.42 |

## Other views

- [Metrics](https://sponda.capital/en/CLAZF.md)
- [Charts](https://sponda.capital/en/CLAZF/charts.md)
- [Compare](https://sponda.capital/en/CLAZF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.